Skip to main content
. 2023 Feb 3;102(5):e32811. doi: 10.1097/MD.0000000000032811

Table 2.

Mortality of TB/HIV co-infected patients.

Characteristics
Person months (pm) Number of deaths Mortality per 1000 pm
Crude mortality 5673 44 7.76
Mortality since TB treatment started
 3rd mo 73 23 315.07
 6th mo 3183 38 11.94
 12th mo 5673 44 7.76
Gender
 Female 1106 5 4.52
 Male 4567 39 8.54
Age group (yr)
 0–20 147 0 0.00
 21–40 2525 20 7.92
 41–60 2117 17 8.03
 >60 884 7 7.92
Ethnicity
 Han 3017 30 9.94
 Yi 2528 13 5.14
 Others 128 1 7.81
Occupation
 Unemployed 5182 41 7.91
 Employed 341 2 5.87
 Unknown 150 1 6.67
Referral type
 Self-referral 1640 11 6.71
 Tracing 3957 33 8.34
 Others 69 0 0.00
Patient type
 New 5151 40 7.77
 Re-treatment 522 4 7.66
Health facility level
 County-level 5336 38 7.12
 City-level 337 6 17.80
Anatomical site of TB
 PTB 4937 33 6.68
 PTB and EPTB 736 11 14.95
TB results
 Bacteriologically unconfirmed 3159 18 5.70
 Bacteriologically confirmed 2514 26 10.34
Severely ill
 No 5277 39 7.39
 Yes 396 5 12.63
ART initiation
 Yes 3297 16 4.85
 No 2376 28 11.78
CD4+T-lymphocyte count (cells/μL)
 ≥200 1474 4 2.71
 <200 1107 14 12.65
 Unknown/missing 3092 26 8.41

ART = anti-retroviral therapy, CD4 = cluster of differentiation 4, EPTB = extra-pulmonary tuberculosis, HIV = human immunodeficiency virus, PTB = pulmonary tuberculosis, TB = tuberculosis.